U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1997
189
Name Type Language
SH-POLYPEPTIDE-59
INCI  
INCI  
Preferred Name English
BECAPLERMIN
EMA EPAR   INN   MART.   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
BECAPLERMIN [USAN]
Common Name English
PLATELET-DERIVED GROWTH FACTOR BETA POLYPEPTIDE
Common Name English
GEMESIS
Brand Name English
Becaplermin [WHO-DD]
Common Name English
GEM 21S
Code English
PLATELET-DERIVED GROWTH FACTOR BECAPLERMIN [MI]
Common Name English
PLATELET-DERIVED GROWTH FACTOR B CHAIN
Common Name English
RECOMBINANT HUMAN PLATELET DERIVED GROWTH FACTOR BB
Common Name English
BECAPLERMIN [MART.]
Common Name English
PLATELET DERIVED GROWTH FACTOR-BB
Common Name English
BECAPLERMIN [EMA EPAR]
Common Name English
PDGFB
Common Name English
PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
Common Name English
PDGF-2
Common Name English
RWJ 60235
Code English
GEM-21S
Code English
BECAPLERMIN [VANDF]
Common Name English
becaplermin [INN]
Common Name English
PLATELET-DERIVED GROWTH FACTOR BECAPLERMIN
MI  
Common Name English
BECAPLERMIN [PURPLE BOOK CDER]
Common Name English
BF-PLATELET DERIVED GROWTH FACTOR .BETA. POLYPEPTIDE
Brand Name English
RWJ-60235
Code English
REGRANEX
Brand Name English
PDGF-BB
Common Name English
Classification Tree Code System Code
WHO-ATC A01AD08
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NDF-RT N0000008077
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
EMA ASSESSMENT REPORTS REGRANEX (WITHDRAWN: WOUND HEALING)
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NDF-RT N0000175885
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NDF-RT N0000008077
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
FDA ORPHAN DRUG 310410
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NDF-RT N0000008077
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
WHO-VATC QA01AD08
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
FDA ORPHAN DRUG 233106
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NCI_THESAURUS C755
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
EMA ASSESSMENT REPORTS GEMESIS (REFUSED: GUIDED TISSUE REGENERATION, PERIODONTAL)
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
WHO-VATC QD03AX06
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
NDF-RT N0000008077
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
WHO-ATC D03AX06
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
Code System Code Type Description
RXCUI
115238
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
BECAPLERMIN
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
DRUG BANK
DB00102
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
DRUG CENTRAL
4925
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
INN
7454
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID70858772
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
IUPHAR
5039
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
CAS
165101-51-9
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
SMS_ID
100000089372
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
NCI_THESAURUS
C1668
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
EVMPD
SUB00680MIG
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
USAN
GG-75
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
FDA UNII
1B56C968OA
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201556
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
DAILYMED
1B56C968OA
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY
MERCK INDEX
m8909
Created by admin on Wed Apr 02 09:34:23 GMT 2025 , Edited by admin on Wed Apr 02 09:34:23 GMT 2025
PRIMARY Merck Index
ACTIVE MOIETY
BECAPLERMIN
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966